. 2021 Apr 1;16(4):e0249455. doi: 10.1371/journal.pone.0249455

Table 2. Underlying pulmonary conditions and their effect on survival of 264 CPA patient.

	Patients	Kaplan-Meier analysis			Cox-proportional hazards model including all underlying conditions and age
	Patients	2-year survival		Log rank test p-value	Adjusted hazard ratio (95% CI)	p-value
TB	156 [59.1]	with	74.4±3.9	0.62	0.94 (0.61–1.46)	0.79
TB	156 [59.1]	without	64.7±5.0	0.62	0.94 (0.61–1.46)	0.79
NTM	87 [33.0]	with	72.5±5.3	0.81	0.95 (0.60–1.51)	0.83
NTM	87 [33.0]	without	69.0±3.8	0.81	0.95 (0.60–1.51)	0.83
Emphysema	115 [43.6]	with	70.4±4.8	0.99	0.87 (0.57–1.32)	0.51
Emphysema	115 [43.6]	without	69.9±4.1	0.99	0.87 (0.57–1.32)	0.51
Pneumothorax	9 [3.4]	with	55.6±16.6	0.28	1.36 (0.54–3.41)	0.52
Pneumothorax	9 [3.4]	without	70.7±3.2	0.28	1.36 (0.54–3.41)	0.52
Bronchiectasis	46 [17.4]	with	79.3±6.6	0.22	0.73 (0.39–1.36)	0.32
Bronchiectasis	46 [17.4]	without	68.2±3.5	0.22	0.73 (0.39–1.36)	0.32
Thoracic surgery	33 [12.5]	with	72.0±8.5	0.51	1.20 (0.66–2.19)	0.54
Thoracic surgery	33 [12.5]	without	69.9±3.3	0.51	1.20 (0.66–2.19)	0.54
ILA	53 [20.1]	with	52.9±7.4	<0.001	1.96 (1.25–3.10)	0.004
ILA	53 [20.1]	without	75.1±3.3	<0.001	1.96 (1.25–3.10)	0.004

Data are presented as n [%] or % ± SE. TB: tuberculosis; NTM: non-tuberculous mycobacteria; ILA: interstitial lung abnormalities. There were two CPA patients complicated with sarcoidosis, but it was too small to justify statistical analysis.